Please login to the form below

Video: Immuno-oncology therapies

Immuno-oncology therapies which harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. However, these therapies come with a very high price tag and currently only a few of these drugs have actually reached the market including Opdivo, Keytruda and Yervoy. In this video Director Sue Marett discusses the opportunities and challenges for new immuno-oncology therapies and outlines what these mean for pharma market research.

http://www.researchpartnership.com/news/2016/05/video-immuno-oncology-therapies/

6th July 2016

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Add my company

Edit my company

Latest content on this profile

EphMRA Annual Conference 2018: Visit us on stand number 20
Research Partnership
Live from Singapore: Full speed ahead - Unlock the full potential of your brand tracking: Thursday 28th June 16:00 SGT/ 16:00 CST / 17:00 JST
Research Partnership
Connected Patients - Adopting a patient-centric approach in emerging markets: Research Partnership
Combination therapies in oncology: The benefits of integrated insights: 14 June 2018 11am EDT | 8am PDT | 4pm BST | 5pm CE
Research Partnership
Intellus round up 2018: Earlier this month, US President Harriet Kozak and Emerging Markets Director Rachel Howard attended the inaugural Intellus Worldwide Summit in Philadelphia
Research Partnership
Janssen & Research Partnership win prestigious BHBIA Best Business Impact award: Research Partnership